Ligand validation:2A06

SMA: STIGMATELLIN A

SMA is a Ligand Of Interest in 2A06 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2A06_SMA_C_2001	64%	42%	0.158	0.958	1.31	0.95	6	2	3	0	100%	1
2A06_SMA_P_3001	62%	43%	0.162	0.955	1.36	0.88	7	2	3	0	100%	1
1PPJ_SMA_C_2001	74%	38%	0.133	0.965	1.62	0.85	9	2	2	0	100%	1
1PP9_SMA_C_2001	67%	37%	0.132	0.939	1.4	1.09	7	4	1	0	100%	1
3CX5_SMA_C_4005	79%	57%	0.107	0.954	0.77	0.89	-	3	1	0	100%	1
3CXH_SMA_N_4025	75%	54%	0.132	0.967	1	0.8	3	1	1	0	100%	1
2YIU_SMA_D_502	71%	17%	0.155	0.976	1.79	1.83	7	14	2	0	100%	1
2JBL_SMA_L_1277	69%	35%	0.146	0.96	1.66	0.92	9	2	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.